The 3q Oncogene ISEC62/I Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer

In the absence of targeted treatment options, neoadjuvant chemotherapy (NACT) is applied widely for triple-negative breast cancer (TNBC). Response to NACT is an important parameter predictive of oncological outcomes (progression-free and overall survival). An approach to the evaluation of predictive...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of molecular sciences 2023-05, Vol.24 (11)
Hauptverfasser:	Radosa, Julia C, Kasoha, Mariz, Doerk, Merle, Cullmann, Annika, Kaya, Askin C, Linxweiler, Maximilian, Radosa, Marc P, Takacs, Zoltan, Tirincsi, Andrea, Lang, Sven, Jung, Ma, Puppe, Julian, Linxweiler, Barbara, Wagner, Mathias, Bohle, Rainer M, Solomayer, Erich-Franz, Zimmermann, Julia S. M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Analysis Breast cancer Cancer Genetic aspects Pharmaceutical industry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!